Homeopathic Drug Product Safety, Quality, and Transparency Act

The Homeopathic Drug Product Safety, Quality, and Transparency Act, designated as H.R. 7050 in the 119th Congress and introduced on January 14, 2026, aims to address safety, quality, and transparency issues related to homeopathic drug products. The bill likely includes provisions to enhance the regulation and oversight of these products to ensure consumer safety and efficacy. Specific directives may involve increased product testing requirements, labeling standards, or reporting mechanisms to provide more comprehensive information to the public regarding the use and effects of homeopathic remedies.